X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3723) 3723
Book Review (560) 560
Publication (171) 171
Conference Proceeding (94) 94
Book Chapter (37) 37
Web Resource (21) 21
Book / eBook (17) 17
Magazine Article (9) 9
Newsletter (2) 2
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2011) 2011
humans (1957) 1957
atrial fibrillation (1173) 1173
female (1013) 1013
male (981) 981
cardiac & cardiovascular systems (912) 912
stroke (825) 825
risk factors (820) 820
aged (792) 792
middle aged (668) 668
abridged index medicus (498) 498
warfarin (497) 497
atrial fibrillation - drug therapy (491) 491
peripheral vascular disease (491) 491
anticoagulants (468) 468
anticoagulants - therapeutic use (450) 450
atrial fibrillation - complications (450) 450
stroke - prevention & control (405) 405
mortality (349) 349
cardiac arrhythmia (329) 329
medicine, general & internal (325) 325
risk (315) 315
cardiovascular (305) 305
hypertension (305) 305
aged, 80 and over (294) 294
stroke - etiology (291) 291
treatment outcome (283) 283
prevention (280) 280
risk assessment (278) 278
thromboembolism (273) 273
management (260) 260
prognosis (256) 256
stroke prevention (255) 255
anticoagulation (253) 253
hematology (251) 251
heart failure (250) 250
care and treatment (247) 247
cardiology (244) 244
anticoagulants - adverse effects (237) 237
atrial fibrillation - epidemiology (226) 226
anticoagulants - administration & dosage (221) 221
aspirin (221) 221
adult (219) 219
administration, oral (215) 215
therapy (208) 208
follow-up studies (193) 193
drug therapy (192) 192
atrial fibrillation - diagnosis (187) 187
antithrombotic therapy (185) 185
stroke - epidemiology (185) 185
internal medicine (182) 182
dabigatran (177) 177
thrombosis (172) 172
hemorrhage - chemically induced (170) 170
warfarin - therapeutic use (168) 168
patients (160) 160
cardiovascular disease (159) 159
analysis (158) 158
fibrillation (157) 157
myocardial-infarction (153) 153
prevalence (153) 153
incidence (150) 150
prospective studies (148) 148
oral anticoagulation (146) 146
bleeding (144) 144
atrial fibrillation - therapy (142) 142
thromboembolism - prevention & control (142) 142
biomarkers - blood (139) 139
guidelines (139) 139
disease (137) 137
atrial-fibrillation (135) 135
pharmacology & pharmacy (134) 134
fibrinolytic agents - therapeutic use (130) 130
registries (130) 130
risk-factors (129) 129
rivaroxaban (128) 128
ischemic-stroke (125) 125
research (125) 125
atrial fibrillation - physiopathology (124) 124
acute myocardial-infarction (123) 123
platelet aggregation inhibitors - therapeutic use (122) 122
predicting stroke (122) 122
cohort studies (121) 121
comorbidity (121) 121
atrial fibrillation - mortality (120) 120
time factors (119) 119
heart attacks (118) 118
von-willebrand-factor (118) 118
randomized controlled trials as topic (116) 116
metaanalysis (113) 113
thromboembolism - etiology (113) 113
health aspects (112) 112
atherosclerosis (111) 111
heart (111) 111
atrial fibrillation - blood (109) 109
clinical neurology (109) 109
vitamin k - antagonists & inhibitors (109) 109
cardiovascular diseases (108) 108
cross-sectional studies (108) 108
apixaban (107) 107
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3751) 3751
Spanish (39) 39
Polish (7) 7
Italian (6) 6
Portuguese (6) 6
German (4) 4
Turkish (2) 2
French (1) 1
Japanese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, ISBN 9781846920462, ix, 214
Aimed at doctors with a general interest in cardiology as well as specialists. "Problem Solving in Cardiology" will appeal to a wide audience of physicians who... 
Heart Diseases
Book
Nature Reviews Drug Discovery, ISSN 1474-1776, 06/2012, Volume 11, Issue 6, pp. 434 - 434
Journal Article
CIRCULATION, ISSN 0009-7322, 10/2009, Volume 120, Issue 15, pp. F88 - F89
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 09/2007, Volume 13, Issue 25, p. 2538
  This issue of Current Pharmaceutical Design, for which I have the honour to be Executive Guest Editor, addresses issues relating to the clinical management... 
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 08/2003, Volume 9, Issue 21, p. 1
  This issue of Current Pharmaceutical Design which is devoted to antihypertensive drugs, has a very clinical slant, hopefully to 'set the scene' for future... 
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 05/2006, Volume 12, Issue 13, p. 1555
  This issue of Current Pharmaceutical Design, for which I have the honour to be Executive Guest Editor, addresses topical issues relating to the clinical... 
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 11/2004, Volume 10, Issue 29, p. 1
  This issue of Current Pharmaceutical Design, for which I have the honour to be Executive Guest Editor, addresses topical issues relating to the treatment of... 
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Index Medicus | Abridged Index Medicus | Trial Design
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 8, pp. 738 - 746
Objectives This study sought to perform an indirect comparison analysis of dabigatran etexilate (2 doses), rivaroxaban, and apixaban for their relative... 
Cardiovascular | Internal Medicine | indirect comparisons | dabigatran | atrial fibrillation | rivaroxaban | apixaban | stroke prevention | NETWORK | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | METAANALYSIS | RISK | THERAPY | WARFARIN | ASSOCIATION | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Dabigatran | Pyridones - administration & dosage | Rivaroxaban | Clinical Trials, Phase III as Topic | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Female | Benzimidazoles - adverse effects | Odds Ratio | Morpholines - adverse effects | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Pyrazoles - adverse effects | Pyridines - therapeutic use | Stroke - prevention & control | Pyridines - administration & dosage | Administration, Oral | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Stroke - etiology | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Pyridones - adverse effects | Stroke (Disease) | Usage | Analysis | Atrial fibrillation | Anticoagulants (Medicine) | Universities and colleges | Cardiology | Anticoagulants | Cardiac arrhythmia | Stroke | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Nature Reviews Cardiology, ISSN 1759-5002, 11/2017, Volume 14, Issue 11, pp. 627 - 628
The Atrial fibrillation Better Care (ABC) pathway for integrated management provides a simple strategy (Avoid stroke, Better symptom management, and... 
STROKE | CARDIAC & CARDIOVASCULAR SYSTEMS | QUALITY | WARFARIN | SAME-TT2R2 SCORE | ATRIAL-FIBRILLATION | ANTICOAGULATION | Aspirin | Care and treatment | Exercise | Atrial fibrillation | Dosage and administration | Thrombolytic drugs | Diagnosis | Health aspects
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article